The glutathione shunt is one of the most important contributors to the cellular redox state, with implications across cancer, chronic diseases, diseases of ageing, and autoimmune diseases, including inflammatory bowel disease (IBD). Traditionally, the redox state is gauged by the ratio of the surrogate metabolites GSH and GSSG. However, this presents methodological challenges and offers a constrained illustration of metabolites without a systems-level understanding of redox dynamics, failing to elucidate variations across an entire biochemical network. Targeted proteomics can fill this void. Here, we describe an in-parallel metabolomic and proteomic targeted method to encompass measurements directly related to the shunt. Samples are simultaneously prepared to extract the substrate building blocks, cysteine, cystine, methionine, glutamic acid, and kynurenine; and the proteins, SLC7A11 (xCT), Glutamate Cysteine Ligase (GSH1), Glutathione Synthetase (GSH2), Glutathione Peroxidase (GPx), and Glutathione Reductase (GSHR) for targeted mass spectrometry. We demonstrate the method by targeted analysis of proteins in plasma, serum, nasal swab, and saliva and apply the multi-omic method to assess changes in the glutathione shunt in the serum of patients diagnosed with IBD. This allows for a broader narrative to establish context at which the glutathione shunt is operating.
NOTCH3 is a highly conserved transmembrane receptor implicated in CADASIL, a hereditary small-vessel disease caused predominantly by mutations affecting its extracellular EGF-like repeats. The mechanisms by which these muta-tions cause pathology remain incompletely understood. We present the first large-scale comparative bioinformatics and molecular dynamics (MD) analysis of NOTCH3 across 113 mammalian species, revealing three novel findings: (i) near-complete conservation of all 204 cysteine residues, with the only exception being eight naturally occurring cysteine substitutions in jaguar EGFr13–15; (ii) a unique deletion within the regulatory region of Brandt’s bat that may increase protease accessibility and alter receptor signaling; and (iii) a rare human NOTCH3-X1 isoform, absent from most mam-mals but shared with select primates, a bat, and elephants, involving a cysteine-depleting deletion spanning EGFr20–22. These naturally occurring exceptions demonstrate that alterations predicted to be deleterious under current pathogenic-ity models can be tolerated in specific evolutionary contexts. Together, these findings provide new insights into the structure–function relationships of NOTCH3, refine the interpretation of CADASIL-associated variants, and identify testable targets for future experimental studies. Our study highlights the power of comparative bioinformatics to uncover previously unrecognized functional features in disease-associated mammalian proteins.